Prostate cancer is the second most commonly diagnosed cancer among men worldwide, with an estimated 1.55 million new cases in ...

There are several strategies for the early detection of prostate cancer. The first step is often a blood test for prostate-specific antigen (PSA). If PSA levels exceed a certain threshold, the next ...

A systematic review of eight studies finds that higher prostate MRI quality shows inconsistent and very-low-certainty associations with the confirmation of clinically significant prostate cancer among ...

High-resolution microultrasonography-guided biopsy was non-inferior to MRI fusion-guided biopsy for detecting clinically significant prostate cancer (detection rates, 47.1% and 42.6%, respectively), a ...

Prostate cancer is the second-leading cause of cancer deaths in American men. Further, non-Hispanic Blacks have a higher incidence of prostate cancer and are more likely to die from it than are ...

These findings show how AI applications ... can support clinicians at one of the most consequential decision points in ...

When former President Joe Biden was diagnosed with an aggressive form of prostate cancer, it generated discussion on screening protocols and what might be possible to detect this condition sooner.

Jairam Eswara, MD, FACS, is a nationally recognized urology specialist and a Fellow of the American College of Surgeons. He’s the Chair of the Department of Urology at Tufts Medical Center and an ...

Biparametric MRI, which omits the dynamic contrast enhancement sequence, can detect clinically significant prostate cancer as well as multiparametric MRI. Biparametric MRI performs as well as ...